Elevated IOP
Showing 1 - 25 of 3,856
Intraocular Pressure Trial in New York (Increasing of intraocular pressure (IC))
Recruiting
- Intraocular Pressure
- Increasing of intraocular pressure (IC)
-
New York, New YorkNYU Langone Health
Mar 10, 2022
Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)
Active, not recruiting
- Glaucoma
- Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
-
Mission Hills, California
- +20 more
Jan 6, 2023
Unmedicated IOP Before and After Treatment Trial in Oakville (Bionode IOP Lowering System)
Unknown status
- Unmedicated IOP Before and After Treatment
- Bionode IOP Lowering System
-
Oakville, Ontario, CanadaPrism Eye Institue
Jan 21, 2020
Glaucoma, Ocular Hypertension Trial in United States (latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic
Completed
- Glaucoma
- Ocular Hypertension
- latanoprost 0.005% ophthalmic solution
- +2 more
-
Bellflower, California
- +39 more
Feb 1, 2021
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic
Recruiting
- Primary Open Angle Glaucoma
- Ocular Hypertension
- SBI-100 Ophthalmic Emulsion, 0.5%
- +2 more
-
Glendale, California
- +2 more
Nov 17, 2023
Sturge-Weber Syndrome (SWS), Glaucoma, Glaucoma Congenital Trial in Durham (QLS-101ophthalmic solution 1%, QLS-101ophthalmic
Active, not recruiting
- Sturge-Weber Syndrome (SWS)
- +3 more
- QLS-101ophthalmic solution 1%
- QLS-101ophthalmic solution 2%
-
Durham, North CarolinaDuke Eye Center
Jul 19, 2022
Macular Disease Trial in Omaha
Suspended
- Macular Disease
-
Omaha, Nebraska
- +1 more
Sep 16, 2022
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzol 20 mg/ml, Trusopt 20 mg/ml)
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzol 20 mg/ml
- Trusopt 20 mg/ml
-
Kazan, Russian FederationState autonomous healthcare institution 'Republican Clinical Oph
Jul 26, 2023
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
- Cosopt eye drops, 20 mg/mL + 5 mg/mL
-
Kazan, Russian FederationRepublican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023
Myopia, Myopic Astigmatism Trial in United States (EVO ICL)
Recruiting
- Myopia
- Myopic Astigmatism
- EVO ICL
-
Overland Park, Kansas
- +6 more
Sep 15, 2022
Glaucoma Trial in Mansoura (Supracapsular Ahmed Glaucoma Valve plate delivery technique)
Completed
- Glaucoma
- Supracapsular Ahmed Glaucoma Valve plate delivery technique
-
Mansoura, Dakahlia, EgyptDina Abd Elfattah
Sep 3, 2022
ALL, Childhood, Steroid-Induced Glaucoma Trial in Petach Tikva (Intraocular pressure measurment)
Recruiting
- ALL, Childhood
- Steroid-Induced Glaucoma
- Intraocular pressure measurment
-
Petach Tikva, IsraelSchneider Children's Medical Center of Israel
Oct 21, 2021
Elevated Intraocular Pressure Trial in United States (Latanoprost ophthalmic solution, 0.005%, TC-002 latanoprost ophthalmic
Active, not recruiting
- Elevated Intraocular Pressure
- Latanoprost ophthalmic solution, 0.005%
- TC-002 latanoprost ophthalmic solution, 0.005%
-
Garden Grove, California
- +19 more
May 23, 2022
Narrow-Angle Glaucoma Trial in Mansoura (Arm 1 : VCST-phaco group , Arm 2 : phaco group.)
Completed
- Narrow-Angle Glaucoma
- Arm 1 : VCST-phaco group , Arm 2 : phaco group.
-
Mansoura, Dakahlia, EgyptMansoura University
Nov 4, 2023
Intraocular Pressure, Oncology Trial in Gainesville (TIVA, Balanced anesthesia)
Recruiting
- Intraocular Pressure
- Oncology
- TIVA
- Balanced anesthesia
-
Gainesville, FloridaUniversity of Florida
Oct 26, 2022
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial (Netarsudil Ophthalmic)
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- Proliferative Vitreoretinopathy
- Netarsudil Ophthalmic
- (no location specified)
Sep 9, 2023
Sturge-Weber Syndrome, Glaucoma, Ocular Hypertension Trial (QLS-101 ophthalmic solution, 2.0 %)
Not yet recruiting
- Sturge-Weber Syndrome
- +2 more
- QLS-101 ophthalmic solution, 2.0 %
- (no location specified)
Aug 8, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Netarsudil/Latanoprost 0.02%/0.005%, GANFORT®)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Netarsudil/Latanoprost 0.02%/0.005%
- GANFORT®
-
Graz, Austria
- +67 more
Jan 24, 2022
Assessment of the Occuity PM1 Pachymeter
Completed
- Glaucoma Eye
-
Reading, Berkshire, United KingdomOccuity Limited
May 31, 2023
Normal Tension Glaucoma andCrucial Step in Preventing Blindness
Not yet recruiting
- Normal Tension Glaucoma
- Obstructive Sleep Apnea
- Clinical observation, diagnostic testing
-
New York, New York
- +1 more
Aug 28, 2023
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (LL-BMT1)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
-
Newport Beach, CaliforniaEye Research Foundatoin
Jun 7, 2022
Glaucoma Trial in Stockholm (Salovum, Placebo)
Terminated
- Glaucoma
- Salovum
- Placebo
-
Stockholm, SwedenSt Erik Eye Hospital
May 11, 2021
Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Nebivolol Ophthalmic Suspension 1 Percent
- +3 more
-
Newport Beach, CaliforniaSite 0012
Jul 18, 2022
Effect of Vitamin Supplementation in Glaucoma Patients
Completed
- Glaucoma
- +3 more
- Ocufolin forte
-
Oudenburg, BelgiumDevogelaere Vision
Oct 5, 2021
Primary Open-Angle Glaucoma Trial in Izmir, Manisa (GlaucoT Glaucoma Treatment Device)
Recruiting
- Primary Open-Angle Glaucoma
- GlaucoT Glaucoma Treatment Device
-
İzmir, Turkey
- +1 more
Mar 19, 2022